Castle Biosciences, Inc. (CSTL) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Castle Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.357 Good afternoon, and welcome to CASEL Biosciences' first quarter 2026 conference 00:00:05.357 -- 00:00:10.062 call. As a reminder, today's call is being recorded. 00:00:10.062 -- 00:00:15.168 We will begin today's call with opening remarks and introductions, followed by a question 00:00:15.168 -- 00:00:20.194 and answer session. I would like to turn the call over to Camila Zuccaro, 00:00:20.194 -- 00:00:23.898 Vice President, Investor Relations and Corporate Affairs. 00:00:23.898 -- 00:00:26.379 Please go ahead. 00:00:26.501 -- 00:00:29.142 Thank you, Operator. Good afternoon, everyone. 00:00:29.142 -- 00:00:34.010 Welcome to CASEL Biosciences first quarter 2026 results conference call. 00:00:34.010 -- 00:00:39.279 Joining me today are CASEL's founder, president, and chief executive officer, Derek Manshold, 00:00:39.279 -- 00:00:42.103 and chief financial officer, Frank Stokes. 00:00:42.103 -- 00:00:46.170 Information recorded on this call speaks only as of today, May 6, 2026. 00:00:46.170 -- 00:00:47.733 Therefore, 00:00:47.733 -- 00:00:52.500 if you're listening to the replay or reading the transcript of this call, any time sensitive 00:00:52.500 -- 00:00:57.077 information may no longer be accurate. A recording of today's call will be available 00:00:57.077 -- 00:01:01.663 on the investor relations page of the company's website for approximately three weeks 00:01:01.663 -- 00:01:06.188 following the conclusion of the call. Before we begin, I would like to remind you that 00:01:06.188 -- 00:01:10.052 some of the statements made today will contain forward-looking statements, including 00:01:10.052 -- 00:01:14.838 statements about expected addressable markets, statements containing projections regarding 00:01:14.838 -- 00:01:19.934 ...